[{"Assets_0_Q2_USD":618218000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-53577000.0,"NetIncomeLoss_2_Q2_USD":-92524000.0,"NetIncomeLoss_1_Q2_USD":-49380000.0,"StockholdersEquity_0_Q2_USD":-43951000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":150261000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":81106000.0,"Ticker":"IRWD","CIK":"1446847","name":"IRONWOOD PHARMACEUTICALS INC","OfficialName":"Ironwood Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1913848067.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180806"}]